Ikarian Capital, LLC - 31 Dec 2025 SCHEDULE 13G Report for Kazia Therapeutics Limited American Depositary Shares, each representing five-hundred Ordinary Shares (KZIA)

Filing Manager: Ikarian Capital, LLC
Reporting Manager: Ikarian Capital, LLC
Security: Kazia Therapeutics Limited American Depositary Shares, each representing five-hundred Ordinary Shares
Symbol: KZIA
Shares outstanding: 11,387,333 shares
Disclosed Ownership: 580,754 shares
Ownership: 5.1%
Form type: SCHEDULE 13G
Filing time: 17 Feb 2026, 17:47:40 UTC
Date of event: 31 Dec 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Ikarian Capital, LLC	5.1%	580,754	0	580,754	/s/ Neil Shahrestani	Neil Shahrestani, Sole Manager
Neil Shahrestani	5.1%	580,754	0	580,754	/s/ Neil Shahrestani	Neil Shahrestani